Literature DB >> 21145442

Dysbindin and Schizophrenia: it's dopamine and glutamate all over again.

Francesco Papaleo1, Daniel R Weinberger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21145442      PMCID： PMC3021467          DOI： 10.1016/j.biopsych.2010.10.028

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  17 in total

1.  Genetic variation in DTNBP1 influences general cognitive ability.

Authors:  Katherine E Burdick; Todd Lencz; Birgit Funke; Christine T Finn; Philip R Szeszko; John M Kane; Raju Kucherlapati; Anil K Malhotra
Journal:  Hum Mol Genet       Date:  2006-01-13       Impact factor: 6.150

2.  DTNBP1 (dysbindin) gene variants modulate prefrontal brain function in healthy individuals.

Authors:  Andreas J Fallgatter; Martin J Herrmann; Christa Hohoff; Ann-Christine Ehlis; Tomasz A Jarczok; Christine M Freitag; Jürgen Deckert
Journal:  Neuropsychopharmacology       Date:  2006-01-11       Impact factor: 7.853

3.  Dysbindin regulates hippocampal LTP by controlling NMDA receptor surface expression.

Authors:  Tina Tze-Tsang Tang; Feng Yang; Bo-Shiun Chen; Yuan Lu; Yuanyuan Ji; Katherine W Roche; Bai Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-01       Impact factor: 11.205

4.  The schizophrenia susceptibility gene dysbindin controls synaptic homeostasis.

Authors:  Dion K Dickman; Graeme W Davis
Journal:  Science       Date:  2009-11-20       Impact factor: 47.728

5.  Role of dysbindin in dopamine receptor trafficking and cortical GABA function.

Authors:  Yuanyuan Ji; Feng Yang; Francesco Papaleo; Huai-Xing Wang; Wen-Jun Gao; Daniel R Weinberger; Bai Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-03       Impact factor: 11.205

6.  Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression.

Authors:  Junxia Tang; Robert P LeGros; Natalia Louneva; Lilly Yeh; Julia W Cohen; Chang-Gyu Hahn; Derek J Blake; Steven E Arnold; Konrad Talbot
Journal:  Hum Mol Genet       Date:  2009-07-19       Impact factor: 6.150

7.  Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients.

Authors:  Cynthia Shannon Weickert; Debora A Rothmond; Thomas M Hyde; Joel E Kleinman; Richard E Straub
Journal:  Schizophr Res       Date:  2007-10-24       Impact factor: 4.939

8.  Neurobehavioral abnormalities in the dysbindin-1 mutant, sandy, on a C57BL/6J genetic background.

Authors:  M M Cox; A M Tucker; J Tang; K Talbot; D C Richer; L Yeh; S E Arnold
Journal:  Genes Brain Behav       Date:  2009-02-11       Impact factor: 3.449

9.  Dysfunction of dopamine release in the prefrontal cortex of dysbindin deficient sandy mice: an in vivo microdialysis study.

Authors:  Taku Nagai; Yuko Kitahara; Anna Shiraki; Takao Hikita; Shinichiro Taya; Kozo Kaibuchi; Kiyofumi Yamada
Journal:  Neurosci Lett       Date:  2010-01-05       Impact factor: 3.046

10.  Dysbindin modulates prefrontal cortical glutamatergic circuits and working memory function in mice.

Authors:  James David Jentsch; Heather Trantham-Davidson; Corey Jairl; Matthew Tinsley; Tyrone D Cannon; Antonieta Lavin
Journal:  Neuropsychopharmacology       Date:  2009-07-29       Impact factor: 7.853
View more
  19 in total

1.  Impaired copper transport in schizophrenia results in a copper-deficient brain state: A new side to the dysbindin story.

Authors:  Kirsten E Schoonover; Stacy L Queern; Suzanne E Lapi; Rosalinda C Roberts
Journal:  World J Biol Psychiatry       Date:  2018-12-20       Impact factor: 4.132

Review 2.  Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies.

Authors:  Colm M P O'Tuathaigh; Paula M Moran; Xuechu C Zhen; John L Waddington
Journal:  Br J Pharmacol       Date:  2017-08-03       Impact factor: 8.739

3.  Are we studying and treating schizophrenia correctly?

Authors:  Neal R Swerdlow
Journal:  Schizophr Res       Date:  2011-06-08       Impact factor: 4.939

Review 4.  Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling.

Authors:  Emily G Severance; Robert H Yolken; William W Eaton
Journal:  Schizophr Res       Date:  2014-07-15       Impact factor: 4.939

5.  Loss of dysbindin-1 in mice impairs reward-based operant learning by increasing impulsive and compulsive behavior.

Authors:  Gregory V Carr; Kimberly A Jenkins; Daniel R Weinberger; Francesco Papaleo
Journal:  Behav Brain Res       Date:  2012-12-20       Impact factor: 3.332

6.  Epistatic interaction between COMT and DTNBP1 modulates prefrontal function in mice and in humans.

Authors:  F Papaleo; M C Burdick; J H Callicott; D R Weinberger
Journal:  Mol Psychiatry       Date:  2013-10-22       Impact factor: 15.992

Review 7.  The involvement of N-methyl-D-aspartate receptor (NMDAR) subunit NR1 in the pathophysiology of schizophrenia.

Authors:  Peijun Ju; Donghong Cui
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-02-01       Impact factor: 3.848

Review 8.  Clinical and molecular genetics of psychotic depression.

Authors:  Katharina Domschke
Journal:  Schizophr Bull       Date:  2013-03-19       Impact factor: 9.306

9.  Loss of dysbindin-1 affects GABAergic transmission in the PFC.

Authors:  H Trantham-Davidson; A Lavin
Journal:  Psychopharmacology (Berl)       Date:  2019-06-14       Impact factor: 4.530

10.  The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans.

Authors:  G M Leggio; S A Torrisi; R Mastrogiacomo; D Mauro; M Chisari; C Devroye; D Scheggia; M Nigro; F Geraci; N Pintori; G Giurdanella; L Costa; C Bucolo; V Ferretti; M A Sortino; L Ciranna; M A De Luca; M Mereu; F Managò; S Salomone; F Drago; F Papaleo
Journal:  Mol Psychiatry       Date:  2019-09-06       Impact factor: 15.992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.